Champions Oncology, Inc. (CSBR)
NASDAQ · Healthcare
Champions Oncology, Inc. Net Income 2018–2025
Champions Oncology, Inc. annual/quarterly net income history and growth rate from 2018 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Champions Oncology, Inc. net income for the quarter ending January 31, 2026 was -279000, a 106.21% decrease year-over-year.
- Champions Oncology, Inc. net income for the twelve months ending January 31, 2026 was 4.0 M, a 258.13% decrease year-over-year.
- Champions Oncology, Inc. annual net income for 2025 was 4.7 M, a 164.61% decrease from 2024.
- Champions Oncology, Inc. annual net income for 2024 was -7.3 M, a 36.38% increase from 2023.
- Champions Oncology, Inc. annual net income for 2023 was -5.3 M, a 1073.54% decrease from 2022.
- Champions Oncology, Inc. annual net income for 2022 was 548000.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Champions Oncology, Inc. Net Income — FAQ
Champions Oncology, Inc. (CSBR) net income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Champions Oncology, Inc.'s net income?
Champions Oncology, Inc. (CSBR) reported net income of $5M for fiscal 2025.
Where can I see CSBR's net income history?
The chart and table above show Champions Oncology, Inc.'s net income by year and by quarter, including the growth rate.